← Fulgent Genetics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($5.3m) |
($2.5m)
+53.06%
|
($5.6m)
-123.39%
|
($411k)
+92.67%
|
$214.3m
+52243.55%
|
$507.4m
+136.74%
|
$143.4m
-71.74%
|
($167.8m)
-217.03%
|
($42.7m)
+74.55%
|
($60.5m)
-41.69%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | ($5.6m) | ($411k) | $214.3m | $506.2m | $141.9m | ($175.2m) | ($43.8m) | ($61.6m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | ($1.1m) | ($1.5m) | ($7.4m) | ($1.1m) | ($1.1m) | — | |
| Depreciation, Depletion and Amortization | $1.2m | $1.7m | $2.2m | $2.1m | $3.0m | $11.0m | $32.7m | $26.1m | $24.9m | $24.1m | $25.8m | |
| Depreciation | $1.2m | $1.7m | $2.2m | $2.1m | $3.0m | $9.3m | $25.5m | $17.5m | $16.4m | $15.7m | $25.8m | |
| Amortization of Intangible Assets | — | — | — | — | — | $1.7m | $6.5m | $7.8m | $8.0m | $8.0m | — | |
| Deferred Income Tax Expense (Benefit) | $246k | ($336k) | $36k | ($21k) | ($1.8m) | ($8.2m) | ($8.3m) | $11.5m | ($3.7m) | ($1.2m) | ($1.4m) | |
| Share-based Payment Arrangement, Noncash Expense | $4.7m | $2.1m | $2.3m | $3.2m | $8.2m | $15.9m | $32.6m | $42.9m | $44.5m | $39.6m | $37.5m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | $4.2m | $1.8m | $2.7m | $2.9m | $3.0m | — | |
| Share-based Payment Arrangement, Expense | $4.7m | $2.1m | $2.3m | $3.2m | $8.2m | $15.9m | $32.6m | $42.9m | $44.5m | $39.6m | $37.5m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | $4.4m | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | $0 | $120.2m | $0 | $0 | $2.2m | |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | — | — | — | — | — | — | $692k | $589k | ($994k) | $62k | — | |
| Income (Loss) from Equity Method Investments | — | ($524k) | ($935k) | ($777k) | ($488k) | — | — | — | — | — | — | |
| Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | $22.0m | $21.1m | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | — | $561k | $153k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $2.3m | ($214k) | $2.0m | $839k | $178.5m | ($42.3m) | ($68.6m) | ($2.4m) | $16.3m | $23.3m | $6.7m | |
| Increase (Decrease) in Accounts Payable | $1.1m | ($363k) | $102k | ($329k) | $22.6m | ($12.2m) | ($25.3m) | ($6.9m) | $3.1m | $550k | ($3.0m) | |
| Net Cash Provided by (Used in) Operating Activities | $4.4m |
$1.3m
-69.78%
|
($675k)
-150.71%
|
$5.5m
+917.33%
|
$140.6m
+2448.99%
|
$538.6m
+282.98%
|
$253.5m
-52.93%
|
$27.0m
-89.35%
|
$21.1m
-22.01%
|
($101.6m)
-582.61%
|
($83.7m)
+17.65%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $3.8m | $2.9m | $2.3m | $1.2m | $35.1m | $23.8m | $18.8m | $22.2m | $40.3m | $22.6m | ($20.1m) | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | — | ($5k) | ($88k) | ($11k) | ($672k) | ($850k) | ($502k) | ($305k) | ($320k) | $3k | ($143k) | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | $61.9m | $172.7m | $399k | $0 | ($3.8m) | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($42.8m) | ($2.0m) | $950k | ($29.0m) | ($326.4m) | ($546.5m) | ($261.3m) | $38.9m | ($58.4m) | $111.4m | $92.0m | |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common Stock | — | — | — | $21k | $62k | — | $74.3m | $25.1m | $225k | $10.9m | — | |
| Proceeds from Issuance of Common Stock | $36.8m | — | — | $28.8m | $246.2m | $89.5m | — | — | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | $45.8m |
($770k)
-101.68%
|
$15k
+101.95%
|
$28.8m
+191733.33%
|
$261.3m
+807.91%
|
$85.4m
-67.31%
|
($77.1m)
-190.32%
|
($47.8m)
+38.05%
|
($4.8m)
+89.86%
|
($14.8m)
-205.12%
|
($70.0m)
-373.57%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $81k | ($44k) | $5.2m | $75.5m | $77.5m | ($85.4m) | $18.0m | ($42.2m) | ($5.0m) | $26.3m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $246k | $12.0m | $87.4m | $164.9m | $79.5m | $97.5m | $55.3m | $50.3m | $26.3m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $81k | ($44k) | ($17k) | $20k | $34k | ($453k) | ($149k) | ($55k) | $105k | $181k | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | $31k | $15k | $38k | $104k | $86k | $31k | $3k | $51k | $1k | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | — | — | — | $960k | $512k | $52k | — | |
| Income Taxes Paid, Net | $550k | $757k | $1k | $20k | $20.6m | $237.1m | $56.2m | $3.3m | $27.6m | $96.4m | — | |
| Additional Financial Items | ||||||||||||
| General and Administrative Expense | $4.6m | $5.2m | $5.5m | $6.4m | $15.2m | $50.7m | $111.1m | $89.0m | $88.1m | $116.7m | — | |
| Goodwill | — | — | — | — | — | $50.9m | $143.0m | $22.1m | $22.1m | $25.1m | $2.2m | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | ($5.4m) | ($2.5m) | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $41k | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $41k | $0 | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $920k | ($1.0m) | $36k | $43k | $72.5m | $174.8m | $42.1m | $1.2m | ($8.1m) | ($8.4m) | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | ($170k) | $75k | — | |
| Investment Income, Interest | — | — | — | — | — | — | — | — | $31.3m | $30.9m | — | |
| Operating Expenses | $10.6m | $13.7m | $15.7m | $18.8m | $41.7m | $101.1m | $188.4m | $300.0m | $181.1m | $222.0m | — | |
| Operating Lease, Lease Income | — | — | — | — | $145k | $420k | $281k | $164k | — | — | — | |
| Proceeds from Noncontrolling Interests | — | — | — | — | — | $10k | — | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | $3.0m | — | — | — | — |